74209-50-0

Usage

Molecular weight

271.3 g/mol

Structure

Tosylate salt of the oxime derivative of 1-pyridin-2-yl-ethanone

Usage

Building block for the production of various drugs and biologically active molecules in organic synthesis and pharmaceutical research

Biological activities

Antioxidant, anti-inflammatory, and neuroprotective effects

Utilization

Reagent in chemical reactions, particularly in the formation of carbon-nitrogen bonds in organic synthesis.

InChI:InChI=1/C14H14N2O3S/c1-11-6-8-13(9-7-11)20(17,18)19-16-12(2)14-5-3-4-10-15-14/h3-10H,1-2H3/b16-12+

Upstream product

• 1758-54-9 1-pyridin-2-yl-ethanone oxime 
• 98-59-9 p-toluenesulfonyl chloride 
• 1122-62-9 2-acetylpyridine 

Downstream Products

• 75140-33-9 2-amino-1-[2]pyridyl-ethanone 
• 74209-42-0 2,2-diethoxy-2-(2-pyridyl)ethylamine 
• 107445-23-8 2,2-diethoxy-2-(2-pyridyl)ethylamine dihydrochloride 
• 51746-81-7 2-amino-1-[2]pyridyl-ethanone; monohydrochloride 

Relevant academic research and scientific papers

A novel octacyanido dicobalt(iii) building block for the construction of heterometallic compounds

The first bimetallic octacyanido complex of CoIII, (PPh4)2[Co2(μ-2,5-dpp)(CN)8] (1), was synthesized and used as a metalloligand with [Mn(MAC)(H2O)2]Cl2·4H2

Gamma-hydroxy-2-(fluoroalkylaminocarbonyl)-1-piperazinepentanamides and uses thereof

γ-Hydroxy-2-(fluoroalkylaminocarbonyl)-1-piperazinepentanamide compounds are inhibitors of HIV protease and inhibitors of HIV replication. These compounds are useful in the prevention or treatment of infection by HV and the treatment of AIDS, either as compounds, pharmaceutically acceptable salts, pharmaceutical composition ingredients, whether or not in combination with other antivirals, immunomodulators, antibiotics or vaccines. Methods of treating AIDS and methods of preventing or treating infection by HIV are also described. These compounds are effective against HIV viral mutants which are resistant to HIV protease inhibitors currently used for treating AIDS and HIV infection.